On the basis of above results, we set out to determine whether CALR expression could predict the tendency of a subset of patients with non-small cell lung cancer (hereafter refer to as lung cancer) or ovarian cancer to respond to ICD-inducers but not non-ICD inducers. The gene discussed is CALR; the disease is lung cancer.